News & Articles
Selected Filters:
Scientists’ Choice Awards Winners Announced for Drug Discovery & Development
Bruker Daltonics and AstraZeneca among those recognized during prestigious ceremony at SLAS2017
Advances in LC-MS Methods for Quantitation of Drugs and Biomarkers in Biological Matrices
Discover how LGC is overcoming the challenges of analyzing peptides with LC-MS
Using LC-MS Approaches to Improve on Traditional Bioanalysis Methods
Learn how the Bioanalysis Department at LGC is implementing LC-MS to improve services
Top Science Trends for 2017
Scientists’ Choice Awards Nominations Open for Best New Drug Discovery & Development Product of 2016
Which new product, instrument or consumable made the most difference to your laboratory?
Insights on Neurodegenerative Diseases
Interview with: Gary Romano, Head of Development, Alzheimer’s Disease & Neurology, Johnson and Johnson
FDA Grants Emergency Use Authorization for Hologic's Aptima<sup>®</sup> Zika Virus Assay
New diagnostic test for the detection of the Zika virus now available for use on fully automated Panther system
Beckman Coulter Showcases Integrated Product-Service Solutions at 2016 AACC Annual Scientific Meeting and Clinical Lab Expo
Beckman Coulter addresses critical factors for clinical laboratories to move healthcare forward
Imaging Technology Partnership Accelerates Biomedical Research in Australia
The University of Sydney has purchased advanced MRI systems from MR solutions as part of a technology collaboration with local distributor AXT Pty Ltd
New Method to Assess Effectiveness of Genome-Editing Technologies
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Innovations in Immunoassay Techniques Used to Analyze Biopharmaceutical Drugs and Biomarkers
Find out how new immunoassay techniques are being used to analyze samples from preclinical and clinical trials
Adapting to Fast-Emerging Medical Threats with Optimized Biotherapeutic Stability
SelectScience® spoke to Rebecca Gentile, Senior Specialist in Quality, Vaccine and Biological Stability at Merck, about the future and current challenges of her work